- Investing Ideas
- /
- French Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
French Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
3
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
3 companies
Eurofins-Cerep
Market Cap: €103.9m
Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.
ALECR
€20,600.00
7D
0%
1Y
-10.4%
OSE Immunotherapeutics
Market Cap: €131.4m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€5.89
7D
-1.3%
1Y
-25.0%
Genfit
Market Cap: €185.3m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
GNFT
€3.72
7D
-7.5%
1Y
-23.3%